J.P. Morgan Private Wealth Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $754K | Sell |
14,484
-284
| -2% | -$14.8K | ﹤0.01% | 1083 |
|
|
2023
Q2 | $935K | Sell |
14,768
-1,057
| -7% | -$66.9K | ﹤0.01% | 782 |
|
|
2023
Q1 | $857K | Buy |
15,825
+2,631
| +20% | +$142K | ﹤0.01% | 1239 |
|
|
2022
Q4 | $698K | Buy |
13,194
+3,306
| +33% | +$175K | ﹤0.01% | 1323 |
|
|
2022
Q3 | $460K | Buy |
9,888
+5,485
| +125% | +$255K | ﹤0.01% | 1499 |
|
|
2022
Q2 | $251K | Buy |
4,403
+154
| +4% | +$8.78K | ﹤0.01% | 1739 |
|
|
2022
Q1 | $260K | Buy |
+4,249
| New | +$260K | ﹤0.01% | 1808 |
|